ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,113.86
0.27%
US Tech 100
17,306.80
0.39%
Dow Jones
38,344.74
0.27%
Brent Oil
87.51
-0.19%
Bitcoin
62,793.07
-0.30%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Vivoryon Therapeutics Nv (0R3M) Quote

Vivoryon Therapeutics Nv

Vivoryon Therapeutics Nv (0R3M)

LSE
4.71
0.00
(0.00%)
Closed April 29 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
4.71
Bid
0.00
Ask
0.00
Volume
4,783
0.00 Day's Range 0.00
4.71 52 Week Range 4.71
Market Cap
-
Previous Close
4.71
Open
-
Last Trade
6
@
0.76
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
6,344
Shares Outstanding
0.00
Dividend Yield
-
PE Ratio
-
Earnings Per Share (EPS)
-
Revenue
-
Net Profit
-

About Vivoryon Therapeutics Nv

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.vivoryon.com
Headquarters
Halle, Deu
Founded
1970
Vivoryon Therapeutics Nv is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker 0R3M. The last closing price for Vivoryon Therapeutics Nv was 4.71 €. Over the last year, Vivoryon Therapeutics Nv shares have traded in a share price range of 4.71 € to 4.71 €.

Vivoryon Therapeutics Nv currently has 0 shares outstanding.

0R3M Latest News

More News

Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates

Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and...

April 24 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. to Report Full Year 2023 Financial Results and Operational Progress on April 24, 2024

Vivoryon Therapeutics N.V. to Report Full Year 2023 Financial Results and Operational Progress on April 24, 2024 Vivoryon Therapeutics N.V. to Report Full Year 2023 Financial Results and...

April 16 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. Announces Changes to Board Composition

Vivoryon Therapeutics N.V. Announces Changes to Board Composition Vivoryon Therapeutics N.V. Announces Changes to Board Composition Halle (Saale) / Munich, Germany, March 15, 2024 – Vivoryon...

March 15 2024
UK Regulatory

Vivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of Varoglutamstat in Early Alzheimer’s Disease

Vivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of Varoglutamstat in Early Alzheimer’s Disease   Vivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of...

March 04 2024
UK Regulatory

Vivoryon Therapeutics N.V. to Host Investor Meetings in January 2024

Vivoryon Therapeutics N.V. to Host Investor Meetings in January 2024 Vivoryon Therapeutics N.V. to Host Investor Meetings in January 2024 Halle (Saale) / Munich, Germany, January 8, 2024 –...

January 08 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. Reports Third Quarter 2023 Financial Results and Highlights Operational Progress

Vivoryon Therapeutics N.V. Reports Third Quarter 2023 Financial Results and Highlights Operational Progress Vivoryon Therapeutics N.V. Reports Third Quarter 2023 Financial Results and...

December 06 2023
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. to Report Q3 2023 Financial Results and Operational Progress on December 6, 2023

Vivoryon Therapeutics N.V. to Report Q3 2023 Financial Results and Operational Progress on December 6, 2023 Vivoryon Therapeutics N.V. to Report Q3 2023 Financial Results and Operational...

November 28 2023
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conference

Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conference Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conference Halle (Saale) / Munich, Germany, November 7, 2023...

November 07 2023
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1004.714.714.71343874.71DE
4004.714.714.71113124.71DE
12004.714.714.7163444.71DE
26004.714.714.7140704.71DE
52004.714.714.7135924.71DE
156004.714.714.7128994.71DE
260004.714.714.7128504.71DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CAUDCollective Audience Inc
$ 0.7442
(90.82%)
137.73M
DCPHDeciphera Pharmaceuticals Inc
$ 25.24
(72.29%)
39.39M
HWHHWH International Inc
$ 2.5935
(42.50%)
22.71M
MULNMullen Automotive Inc
$ 4.48
(41.77%)
31.66M
TSLRGraniteShares ETF Trust GraniteShares
$ 14.445
(34.12%)
1.07M
CLVRClever Leaves Holdings Inc
$ 1.5801
(-61.55%)
611.63k
ADXNAddex Therapeutics Ltd
$ 8.16
(-49.32%)
121.83k
MFImF International Ltd
$ 1.54
(-33.91%)
2.47M
TSDDGraniteShares ETF Trust GraniteShares
$ 16.5051
(-33.71%)
1.13M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
$ 26.07
(-33.61%)
5.48M
TSLATesla Inc
$ 196.67
(16.86%)
157.86M
CAUDCollective Audience Inc
$ 0.7442
(90.82%)
137.73M
SINTSiNtx Technologies Inc
$ 0.0529
(30.94%)
135.2M
SOFISoFi Technologies Inc
$ 7.085
(-9.97%)
110.99M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 9.575
(33.92%)
61.48M

Discussion

View Full Feed
thewolfoftrade thewolfoftrade 3 minutes ago
BARON CAPITAL ENTERPRISE INC
????
0.0007
x100
-0.0001
-12.50%
DELAYED DATA
Ask
Bid
Buy Order
3,613,200 x 0.0007
11,770,800 x 0.0002
BCAP
Golden Cross Golden Cross 3 minutes ago
$AGBA Triller going to see ‘biggest influx’ of users after new TikTok law:
https://www.foxbusiness.com/video/6351757905112
AGBA
sylvia07 sylvia07 3 minutes ago
Happy volume is creeping up! Some say that are looking out for shareholders because they don't want them to lose their money but if you care for shareholders why lie to them and call them names?
DBMM
BobFromCobb BobFromCobb 3 minutes ago
Next emerging growth conference is May 8th/9th. Not sure if they are presenting. Will keep a lookout tho
XESP
monocle monocle 3 minutes ago
I think this news is the one the market hates.

https://www.tipranks.com/news/the-fly/niocorp-announces-closing-of-financing-agreement

Hard believe they could could not come up with better short-term financing than this.

Also, I think it's possible that t
NB
cojoboy cojoboy 3 minutes ago
Just grabbed some .0108's..so it will drop to .0107 now...lol
IGPK
Kool Aid Man Kool Aid Man 3 minutes ago
. Warning ! This security is eligible for Unsolicited Quotes Only

This stock is not eligible for proprietary broker-dealer quotations. All quotes in this stock reflect unsolicited customer orders. Unsolicited-Only stocks have a higher risk of wider spreads, increased volatility, and
SPZI
wisetoit wisetoit 4 minutes ago
Agreed, they said it’s point 25% fee but if it’s not profitable why are they shorting?

Thanks
PSRU
sicofbs sicofbs 4 minutes ago
Reading your bs posts and the cheesy stock lines used over snd over says you need to just stfu and drift on by .😊
IGPK
knrorrel knrorrel 4 minutes ago
DREAM CHART TODAY BOOOOOOOOOOOOOOOOOOOOOOOOOOOM
JAGX
nowwhat2 nowwhat2 4 minutes ago
Hey, where's our "Buy Every Dip And Enjoy The Rip !" guy ?.......
The dumbo who couldn't identify a dip if his life depended on it ?
Where'd he all go and like, where is he NOW ?

Oh that's right too, so nevermind.....(he doesn't show up until AFTER-THE-FACT) !
BTCUSD
KarmaKing KarmaKing 4 minutes ago
You have been knocked in the head too many times of the fact Parkinson is a WELL DOCUMENTED liar that needs to be shut down because of the cheating and stealing. Are you a Fkn Idiot? A WELL DOCUMENTED LIAR...DO YOU UNDERSTAND?...
HHSE
redspeed redspeed 4 minutes ago
A one week NDA? LOL

That's not how these work. He would have had to sign a much longer one.
MONI
crowin crowin 4 minutes ago
Did you know that IGPK is a Wanna be CHINESE SHARE SELLING SCAM?
IGPK
Xrouter Xrouter 4 minutes ago
Not me I’m all out at a little over $3. Hopefully we see it this week but I doubt it very very much. Good luck. Traders are gone and praying to exit at my average
POET
Runners123 Runners123 4 minutes ago
Post# of 641595 Go
APPL AMD prolly dip after open and then resume climb
👍️ 0
AMD
Dead On Arrival Dead On Arrival 4 minutes ago
who cares
LWLG
swingingRichard swingingRichard 5 minutes ago
Any millionaires yet? LMAO
COWI
berigud berigud 5 minutes ago
Searay, there are plenty of other products on the market today that will do what insultex will do. They might not be as thin but that is not important to builders. Tyvek has Thermawrap.

Here is the only issue. Our CEO has proven to be a terrible manager. He has made BAD decision
IVDN
knrorrel knrorrel 5 minutes ago
ASK IS VERY THIN
FLES
Myth Myth 5 minutes ago
Night Flight · Led Zeppelin

https://www.youtube.com/watch?v=YlbBk4hZi-w
georgie18 georgie18 5 minutes ago
NVOS...57...113K top Bidder...🥳
NVOS
Golden Cross Golden Cross 5 minutes ago
$AGBA Triller going to see ‘biggest influx’ of users after new TikTok law:
https://www.foxbusiness.com/video/6351757905112
AGBA
JusDePomme JusDePomme 5 minutes ago
Don't even say 10k$ ..not even 2k 😜
RONN
Investors3 Investors3 5 minutes ago
You are very welcome!
COIN

Your Recent History

LSE
0R3M
Vivoryon Therapeutics Nv
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved